These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2769820)

  • 1. The effect of "superactive" charcoal and magnesium citrate solution on blood ethanol concentrations and area under the curve in humans.
    Katona BG; Siegel EG; Roberts JR; Fant WK; Hassen M
    J Toxicol Clin Toxicol; 1989; 27(1-2):129-37. PubMed ID: 2769820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of activated charcoal on ethanol blood levels in dogs.
    North DS; Thompson JD; Peterson CD
    Am J Hosp Pharm; 1981 Jun; 38(6):864-6. PubMed ID: 7246560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.
    Gomez HF; McClafferty HH; Flory D; Brent J; Dart RC
    Ann Emerg Med; 1997 Nov; 30(5):587-92. PubMed ID: 9360566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral calcium disodium EDTA on iron absorption in a human model of iron overdose.
    Matteucci MJ; Habibe M; Robson K; Baldassano AA; Riffenburgh RH; Tanen DA
    Clin Toxicol (Phila); 2006; 44(1):39-43. PubMed ID: 16496492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration.
    Laine K; Kivistö KT; Pelttari S; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):270-3. PubMed ID: 8936562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H; Kubitza D; Möller JG; Delesen H
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of activated charcoal administration on acetylcysteine serum levels in humans.
    North DS; Peterson RG; Krenzelok EP
    Am J Hosp Pharm; 1981 Jul; 38(7):1022-4. PubMed ID: 7258201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated charcoal in oral ethanol absorption: lack of effect in humans.
    Minocha A; Herold DA; Barth JT; Gideon DA; Spyker DA
    J Toxicol Clin Toxicol; 1986; 24(3):225-34. PubMed ID: 3723647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of magnesium citrate cathartic in pediatric toxic ingestions.
    Sue YJ; Woolf A; Shannon M
    Ann Emerg Med; 1994 Oct; 24(4):709-12. PubMed ID: 8092599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of superactivated charcoal administered to healthy volunteers.
    Sato RL; Wong JJ; Sumida SM; Yamamoto LG
    Hawaii Med J; 2002 Nov; 61(11):251-3. PubMed ID: 12516788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal.
    Lim DT; Singh P; Nourtsis S; Dela Cruz R
    Ann Emerg Med; 1986 Nov; 15(11):1303-7. PubMed ID: 3777587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of magnesium citrate on the in vitro adsorption of aspirin by activated charcoal.
    Lapierre G; Algozzine G; Doering PL
    Clin Toxicol; 1981 Jul; 18(7):793-6. PubMed ID: 7307462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of chloroquine absorption by activated charcoal.
    Neuvonen PJ; Kivistö KT; Laine K; Pyykkö K
    Hum Exp Toxicol; 1992 Mar; 11(2):117-20. PubMed ID: 1349217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 2000 Jul; 56(4):285-8. PubMed ID: 10954340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantage of high-surface-area charcoal for gastrointestinal decontamination in a human acetaminophen ingestion model.
    Roberts JR; Gracely EJ; Schoffstall JM
    Acad Emerg Med; 1997 Mar; 4(3):167-74. PubMed ID: 9063541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.